|
Home : WuXi Biologics Commenced Process Validation in MFG2 |
|
Jul 31 2018 |
WuXi Biologics Commenced Process Validation in MFG2 |
Produced 7 batches at 6,000L/12,000L bioreactor scale for three programs, the largest scale cell culture operations in China at 100% success rate in MFG2, the largest biologics manufacturing facility globally leveraging single-use technology Process validation in MFG2 is a key milestone... |
|
|
Source:https://www.prnewswire.com:443/news-releases/wuxi-biologics-commenced-process-validation-in-mfg2-300688502.html |
|
Related News
|
» Over 35 Speakers From General Motors, FCA, Cummins, Cruise, the FBI, NHTSA, Toyota, Daimler AG, Ford Motor Company and the U.S. Senate to Address Future of Autonomous Cybersecurity » Prosecutors advise witnesses in Manafort trial: Avoid the T-word (Trump) |
|
|